Table 7

Results of intervention tests performed by study number and tumour type

Study numberTumour typeSIBOLactoseBAMSeHCAT retention (%)
1CervixPositiveNegativePositive7
3CervixNegativeNegativePositive9
6Cervix
12CervixInconclusiveNegativePositive11
13CervixPositivePositivePositive0
15CervixNegativePositive14
16CervixPositiveNegativePositive1
20Cervix
22BladderNegativeNegativeNegative33
23BladderNegativeNegativeNegative72
24BladderNegativePositivePositive1
26BladderNegativeNegativePositive14
28BladderNegative
30BladderNegativeNegativeNegative36
32CervixNegativePositivePositive2
34BladderPositivePositiveNegative26
36CervixNegativeNegative36
37BladderNegativeNegativePositive3
39BladderNegativeNegativeNegative51
40BladderNegativeNegativeNegative92
43CervixNegativeNegativePositive4
44Cervix
45BladderNegativePositivePositive5
49CervixPositive8
Number of tests20 (1 inconclusive)1720
Number of positive tests4513
Proportion of positive tests (%)212965
  • BAM, bile acid malabsorption; SeHCAT, Selenium-75-homocholic acid taurine; SIBO, small intestinal bacterial overgrowth.